Nevertheless, preclinical studies demonstrated the anti-obesity effect of OXM since a chronic administration leads to superior weight loss and comparable glucose lowering to a GLP1R-selective peptide [93,94]. This evidence concerns the gene GLP1R and obesity disorder.